The growth-inhibitory effects of tomatoes digested in vitro in colon adenocarcinoma cells occur through down regulation of cyclin D1, Bcl-2 and Bcl-xL

British Journal of Nutrition

Volumn 98, Issue 4, 2007, Pages 789-795

  Palozza, Paola ^a   Serini, Simona ^a   Boninsegna, Alma ^a   Bellovino, Diana ^b   Lucarini, Massimo ^b   Monastra, Giovanni ^b   Gaetani, Sancia ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

Author keywords

Apoptosis; Cell cycle; Colon cancer cells; In vitro digestion; Tomatoes

Indexed keywords

CAROTENOID; CYCLIN D1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P21; PROTEIN P27; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL STRAIN HCT116; CELL STRAIN HT29; COLON ADENOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIGESTION; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; PROTEIN EXPRESSION; TOMATO;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYCLIN D1; DIGESTION; DOWN-REGULATION; FEMALE; HT29 CELLS; HUMANS; LYCOPERSICON ESCULENTUM; MALE; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

LYCOPERSICON ESCULENTUM;

EID: 34748891785     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507746883     Document Type: Article

References (47)

1. Blum A, Monir M, Wirsansky I & Ben-Arzi S (2005) The beneficial effects of tomatoes. Eur J Intern Med 16, 402-404.
2. Agarwal S & Rao AV (2000) Tomato lycopene and its role in human health and chronic diseases. Can Med Assoc J 163, 739-744.
3. Willcox JK, Catignani GL & Lazarus S (2003) Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr 43, 1-18.
4. Rao AV (2002) Lycopene, tomatoes, and the prevention of coronary heart disease. Exp Biol Med (Maywood) 227, 908-913.
5. Giovannucci E (1999) Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature. J Natl Cancer Inst 91, 317-331.
6. Franceschi S, Bidoli E, La Vecchia C, Talamini R, D'Avanzo B & Negri E (1994) Tomatoes and risk of digestive-tract cancers. Int J Cancer 59, 181-184.
7. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA & Willett, WC (1995) Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 87, 1767-1776.
8. Giovannucci E, Rimm EB, Liu Y, Stampfer WC & Willett J (2002) A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94, 391-398.
9. Burney PG, Comstock GW & Morris JS (1989) Serologic precursors of cancer: Serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr 49, 895-900.
10. Davies JN & Hobson GE (1981) The constituents of tomato fruit - the influence of environment, nutrition, and genotype. Crit Rev Food Sci Nutr 15, 205-280.
11. Shi J & Le Maguer M (2000) Lycopene in tomatoes: Chemical and physical properties affected by food processing. Crit Rev Food Sci Nutr 40, 1-42.
12. Campbell JK, Canene-Adams Y, Lindshield BL, Boileau TW, Clinton SK & Erdman JW Jr (2004) Tomato phytochemicals and prostate cancer risk. J Nutr 134, 3486S-3492S.
13. Curl AL (1961) The xanthophylls of tomatoes. J Food Sci 26, 106-111.
14. Shi ML & Le Maguer M (2000) Lycopene in tomatoes: Chemical and physical properties affected by food processing. Crit Rev Biotechnol 20 293-334.
15. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH & Stampfer MJ (1999) Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis. Cancer Res 59, 1225-1230.
16. Heber D & Lu QY (2002) Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood) 227, 920-923.
17. Levy J, Bosin E, Feldman B, Giat Y, Miinster A, Danilenko M & Sharoni Y (1995) Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene. Nutr Cancer 24, 257-266.
18. Xu X, Wang Y, Constantinou AI, Stacewicz-Sapuntzakis M, Bowen PE & van Breemen RB (1999) Solubilization and stabilization of carotenoids using micelles: Delivery of lycopene to cells in culture. Lipids 34 1031-1036.
19. Palozza P, Serini S, Maggiano N, Angelini M, Boninsegna A, Di Nicuolo F, Ranelletti FO & Calviello G (2002) Induction of cell cycle arrest and apoptosis in human colon adenocarcinoma cell lines by β-carotene through down-regulation of cyclin A and Bcl-2 family proteins. Carcinogenesis 23, 11-18.
20. Garrett DA, Failla ML & Sarama RJ (1999) Development of an in vitro digestion method to assess carotenoid bioavailability from meals. J Agric Food Chem 47, 4301-4309.
21. Crissman HA & Steinkamp JA (1973) Rapid, simultaneous measurement of DNA, protein, and cell volume in single cells from large mammalian cell populations. J Cell Biol 59, 766-771.
22. Palozza P, Serini S, Torsello A, Di Nicuolo F, Maggiano N, Ranelletti FO, Wolf FI & Calviello G (2003) Mechanism of activation of caspase cascade during β-carotene-induced apoptosis in human tumor cells. Nutr Cancer 47, 76-87.
23. Palozza P, Sheriff A, Serini S, Boninsegna A, Maggiano N, Ranelletti FO, Calviello G & Cittadini A (2005) Lycopene induces apoptosis in immortalized fibroblasts exposed to tobacco smoke condensate through arresting cell cycle and down-regulating cyclin D1, pAKT and pBad. Apoptosis 10, 1445-1456.
24. Liu CS, Glahn RP & Liu RH (2004) Assessment of carotenoid bioavailability of whole foods using a Caco-2 cell culture model coupled with an in vitro digestion. J Agric Food Chem 52, 4330-4337.
25. Marletta L, Lucarini M, Ruggeri S & Carnovale E (2000) Food composition databases in Italy: Problems and perspectives. J Food Comp Anal 13, 611-618.
26. Etcheverry P, Wallingford JC, Miller DD & Glahn RP (2005) The effect of calcium salts, ascorbic acid and peptic pH on calcium, zinc and iron bioavailabilities from fortified human milk using an in vitro digestion/Caco-2 cell model. Int J Vitam Nutr Res 75, 171-178.
27. Cave NA (1988) Bioavailability of amino acids in plant feedstuffs determined by in vitro digestion, chick growth assay, and true amino acid availability methods. Poult Sci 67, 78-87.
28. Fouad MF, Farrell PG, Marshall WD & van de Voort FR (1991) In vitro model for lipase-catalyzed lipophile release from fats. J Agric Food Chem 39, 150-153.
29. 6 in processed foods. Br J Nutr 55, 235-244.
30. Reboul E, Borel P, Mikail C, Abou L, Charbonnier M, Caris-Veyrat C, Goupy P, Portugal H, Lairon D & Amiot M-J (2005) Enrichment of tomato paste with 6% tomato peel increases lycopene and β-carotene bioavailability in men. J Nutr 135, 790-794.
31. Borel P, Grolier P, Armand M, Partier A, Lafont H, Lairon D & Azais-Braesco V (1996) Carotenoids in biological emulsions: Solubility, surface-to-core distribution, and release from lipid droplets. J Lipid Res 37, 250-261.
32. Kim L, Rao AV & Rao LG (2002) Effects of lycopene on prostate LNCaP cancer cells in culture. J Med Food 5, 181-187.
33. Omoni AO & Aluko RE (2005) The anti-carcinogenic and anti-atherogenic effects of lycopene:a review. Trends Food Sci Technol 16, 344-350.
34. La Vecchia C (2002) Tomatoes, lycopene intake, and digestive tract and female hormone-related neoplasms. Exp Biol Med 227, 860-863.
35. Bhuvaneswari V & Nagini S (2005) Lycopene: A review of its potential as an anticancer agent. Curr Med Chem Anticancer Agents 5, 627-635.
36. Hwang ES & Bowen PE (2005) Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells. Biofactors 23, 97-105.
37. Ben-Dor A, Nahum A, Danilenko M, Giat Y, Stahl W, Martin HD, Emmerich T, Noy N, Levy J & Sharoni Y (2001) Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells. Arch Biochem Biophys 391, 295-302.
38. Hirsch & Atzmon A, Danilenko M, Levy J & Sharoni Y (2006) Lycopene and other carotenoids inhibit estrogenic activity of 17β-estradiol and genistein in cancer cells. Breast Cancer Res Treat, (Epublication ahead of print 19 October 2006).
39. Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J & Sharoni Y (2001) Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene 20, 3428-3436.
40. 3 cooperate in the inhibition of cell cycle progression and induction of differentiation in HL-60 leukemic cells. Nutr Cancer 33, 105-112.
41. Diehl JA (2002) Cycling to cancer with cyclin D1. Cancer Biol Ther 1, 226-231.
42. Hall AK (1996) Liarozole amplifies retinoid-induced apoptosis in human prostate cancer cells. Anticancer Drugs 7, 312-320.
43. Kotake-Nara E, Kushiro M, Zhang H, Sugawara. T, Miyashita K & Nagao A (2001) Carotenoids affect proliferation of human prostate cancer cells. J Nutr 131, 3303-3306.
44. Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J & Sharoni Y (2000) Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 36, 101-111.
45. Hantz HL, Young LF & Martin KR (2005) Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Exp Biol Med (Maywood) 230, 171-179.
46. Nara E, Hayashi H, Kotake M, Miyashita K & Nagao A (2001) Acyclic carotenoids and their oxidation mixtures inhibit the growth of HL-60 human promyelocytic leukemia cells. Nutr Cancer 39, 273-283.
47. Bowen P, Chen L, Stacewicz-Sapuntzakis M, Duncan C, Sharifi R, Ghosh L, Kim HS, Christov Tzelkov K & van Breemen R (2002) Tomato sauce supplementation and prostate cancer: Lycopene accumulation and modulation of biomarkers of carcinogenesis. Exp. Biol Med (Maywood) 227, 886-893.